The Protection of the Person in Medical Research in Germany
Medicine and Law: World Association for Medical Law 1999; 18(1): 77-92
Because of its history Germany has many rules concerning the protection of persons in medical research. In fact Germany was the first state to issue a directive regulating medical experimentation with human beings in the year 1900. The ten principles of Nuremberg originated out of the medical case. Germany adheres to the Revised Declaration of Helsinki of the World Medical Association and will probably sign the European convention on biomedicine. The pharmaceutical act contains elaborate provisions for the protection of the patient or proband, e.g. informed consent, risk-benefit ratio, no experimentation on prisoners, approval of a local ethics committee. Moreover in pharmaceutical trials there has to be third party accident insurance for the experimental subject. There is no strict liability for medical experimentation, but the standard of care is high. In general the German law seems to be adequate for the protection of experimental subjects.
Consent; Ethics; Experimental Subjects; Informed Consent; Insurance; Law; Liability; Medical Research; Prisoners; Research; Risk; Confidentiality; Malpractice; Human Experimentation Policy Guidelines / Institutional Review Boards; Informed Consent or Human Experimentation; Social Control of Human Experimentation; Economics of Health Care;
Showing items related by title, author, creator and subject.
Deutsch, Erwin (1992-06)The "Fetus Protection Law" (Embryonenschutzgesetz ESchG) regulates the abusive use of reproductive techniques, the use of human embryos and the choice of sex. The Bundestag has singled out certain practices as being abusive, ...